Company profile for Aridis Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Our scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early...
Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Our scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early discovery to commercial implementation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5941 Optical Court San Jose, CA 95138
Telephone
Telephone
408-385-1742
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Aridis Provides Corporate Update
Aridis Provides Corporate Update

20 Dec 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/12/20/3000566/0/en/Aridis-Provides-Corporate-Update.html

GLOBENEWSWIRE
20 Dec 2024
Aridis Provides Corporate Update
Aridis Provides Corporate Update

24 Jun 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/06/24/2903410/0/en/Aridis-Provides-Corporate-Update.html

GLOBENEWSWIRE
24 Jun 2024

https://www.globenewswire.com//news-release/2023/12/15/2797283/0/en/Aridis-Pharmaceuticals-Announces-Adjournment-of-Annual-Meeting-of-Stockholders-until-January-12-2024.html

GLOBENEWSWIRE
15 Dec 2023

https://www.globenewswire.com//news-release/2023/11/03/2773449/0/en/Aridis-Pharmaceuticals-Announces-Third-Quarter-2023-Financial-Results-and-Business-Update.html

GLOBENEWSWIRE
03 Nov 2023

https://www.globenewswire.com/news-release/2023/08/02/2716835/0/en/Aridis-Pharmaceuticals-Announces-2-Million-Offering.html

GLOBENEWSWIRE
02 Aug 2023

https://endpts.com/aridis-to-delist-from-nasdaq-bicycle-closes-200m-offering/

Paul Schloesser ENDPTS
18 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty